Skip to main content

Table 1 Baseline characteristics of participants

From: Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial

Characteristics

Intervention group

N = 28

Placebo group

N = 24

p-Value

Age (years)

28.42 ± 6.10

32.75 ± 15.99

0.222

Height (cm)

163.08 ± 4.51

163.06 ± 4.24

0.983

Marital status (%)

   

 Single

 Married

 Widow

 Divorced

15 (53.6%)

12 (42.9%)

0 (0%)

1 (3.6%)

12 (50.0%)

9 (37.5%)

0 (0%)

3 (12.5)

0.481

History of previous pregnancy (%)

   

 Yes

 No

3 (10.7%)

25 (89.3%)

3 (12.5%)

21 (87.5%)

0.841

Duration of PCOS (year)

9.80 ± 6.21

7.48 ± 4.87

0.152

On antidepressant drugs (%)

   

 Yes

 No

4 (14.3%)

24 (85.7%)

3 (12.5%)

21 (87.5%)

0.851

On antianxiety drugs (%)

   

 Yes

 No

2 (7.1%)

26 (92.9%)

3 (12.5%)

20 (83.3%)

0.431

On menstrual-regulating drugs (%)

   

 Yes

 No

5 (55.6%)

23 (53.5%)

4 (44.4%)

20 (46.5%)

1.000

On metformin (%)

   

 Yes

 No

3 (42.9%)

25 (55.6%)

4 (57.1%)

20 (44.4%)

0.531

  1. BMI: Body mass index; PCOS: polycystic ovarian syndrome.
  2. Quantitative variables are mean ± SD and qualitative variables are frequency (percentage).